X4 Pharmaceuticals, Inc. (XFOR)
3.73
-0.12
(-3.12%)
USD |
NASDAQ |
Jun 10, 16:00
3.72
-0.01
(-0.27%)
After-Hours: 20:00
X4 Pharmaceuticals 1 Year Total Returns (Daily) : 4.78% for June 10, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 10, 2026 | 4.78% |
| June 09, 2026 | -7.00% |
| June 08, 2026 | -13.72% |
| June 05, 2026 | 3.51% |
| June 04, 2026 | -0.74% |
| June 03, 2026 | 0.25% |
| June 02, 2026 | 6.04% |
| June 01, 2026 | 20.88% |
| May 29, 2026 | 22.44% |
| May 28, 2026 | 27.38% |
| May 27, 2026 | 18.88% |
| May 26, 2026 | 29.03% |
| May 22, 2026 | 25.08% |
| May 21, 2026 | 45.85% |
| May 20, 2026 | 39.11% |
| May 19, 2026 | 24.66% |
| May 18, 2026 | 26.03% |
| May 15, 2026 | 30.46% |
| May 14, 2026 | 23.46% |
| May 13, 2026 | 27.79% |
| May 12, 2026 | 29.94% |
| May 11, 2026 | 33.53% |
| May 08, 2026 | 34.65% |
| May 07, 2026 | 32.41% |
| May 06, 2026 | 36.02% |
| Date | Value |
|---|---|
| May 05, 2026 | 27.27% |
| May 04, 2026 | 13.02% |
| May 01, 2026 | 11.73% |
| April 30, 2026 | -5.57% |
| April 29, 2026 | -5.75% |
| April 28, 2026 | -22.77% |
| April 27, 2026 | -26.14% |
| April 24, 2026 | -26.82% |
| April 23, 2026 | -29.13% |
| April 22, 2026 | -27.42% |
| April 21, 2026 | -26.42% |
| April 20, 2026 | -26.80% |
| April 17, 2026 | -25.05% |
| April 16, 2026 | -29.34% |
| April 15, 2026 | -30.61% |
| April 14, 2026 | -31.64% |
| April 13, 2026 | -34.45% |
| April 10, 2026 | -35.41% |
| April 09, 2026 | -41.52% |
| April 08, 2026 | -36.38% |
| April 07, 2026 | -41.38% |
| April 06, 2026 | -36.78% |
| April 02, 2026 | -38.01% |
| April 01, 2026 | -34.60% |
| March 31, 2026 | -41.77% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Kyverna Therapeutics, Inc. | 112.8% |
| Arrowhead Pharmaceuticals, Inc. | 316.8% |
| Oncolytics Biotech, Inc. | 87.38% |
| Sangamo Therapeutics, Inc. | -71.08% |
| Sarepta Therapeutics, Inc. | -61.33% |